Literature DB >> 16688334

A paramagnetic contrast agent with myeloperoxidase-sensing properties.

Manel Querol1, John W Chen, Alexei A Bogdanov.   

Abstract

Myeloperoxidase (MPO) is an essential component of inflammatory response in norm and pathology. With an ultimate goal of non-invasive imaging of MPO we used a gadolinium-chelating bis(5-hydroxytrytamide) derivative of diethylenetetraamine pentaacetic acid (L1-Gd3+ salt) as a paramagnetic sensor of enzymatic activity. We tested whether L1-Gd3+ is active in reducing the oxidized form of myeloperoxidase, generated as a result of hydrogen peroxide reduction by the enzyme. We expected that upon activation by MPO/H2O2 L1-Gd3+ would not only oligomerise but also bind to other macromolecules present in the media and that the overall process will give rise to a net T1-weighted MRI signal increase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16688334     DOI: 10.1039/b601540a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  26 in total

Review 1.  Targeted probes for cardiovascular MRI.

Authors:  Ritika Uppal; Peter Caravan
Journal:  Future Med Chem       Date:  2010-03       Impact factor: 3.808

Review 2.  Advances in functional and molecular MRI technologies in chronic liver diseases.

Authors:  Iris Y Zhou; Onofrio A Catalano; Peter Caravan
Journal:  J Hepatol       Date:  2020-06-22       Impact factor: 25.083

3.  Using the neurotransmitter serotonin to target imaging agents to glioblastoma cells.

Authors:  Alexander Sturzu; Sumbla Sheikh; Uwe Klose; Hartmut Echner; Hubert Kalbacher; Martin Deeg; Thomas Nägele; Marius Horger; Ulrike Ernemann; Stefan Heckl
Journal:  Invest New Drugs       Date:  2012-12       Impact factor: 3.850

4.  Multiple sclerosis: myeloperoxidase immunoradiology improves detection of acute and chronic disease in experimental model.

Authors:  Benjamin Pulli; Lionel Bure; Gregory R Wojtkiewicz; Yoshiko Iwamoto; Muhammad Ali; Dan Li; Stefan Schob; Kevin Li-Chun Hsieh; Andreas H Jacobs; John W Chen
Journal:  Radiology       Date:  2014-12-10       Impact factor: 11.105

5.  Activatable magnetic resonance imaging agents for myeloperoxidase sensing: mechanism of activation, stability, and toxicity.

Authors:  Elisenda Rodríguez; Mark Nilges; Ralph Weissleder; John W Chen
Journal:  J Am Chem Soc       Date:  2010-01-13       Impact factor: 15.419

6.  Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.

Authors:  Claudia Calcagno; Sarayu Ramachandran; Antoine Millon; Philip M Robson; Venkatesh Mani; Zahi Fayad
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-10-14

7.  Enzyme-directed assembly of a nanoparticle probe in tumor tissue.

Authors:  Miao-Ping Chien; Matthew P Thompson; Christopher V Barback; Ti-Hsuan Ku; David J Hall; Nathan C Gianneschi
Journal:  Adv Mater       Date:  2013-05-28       Impact factor: 30.849

Review 8.  Detecting enzyme activities with exogenous MRI contrast agents.

Authors:  Dina V Hingorani; Byunghee Yoo; Adam S Bernstein; Mark D Pagel
Journal:  Chemistry       Date:  2014-07-02       Impact factor: 5.236

9.  Nuclear microscopy: a novel technique for quantitative imaging of gadolinium distribution within tissue sections.

Authors:  Reshmi Rajendran; John A Ronald; Tao Ye; Ren Minqin; John W Chen; Ralph Weissleder; Brian K Rutt; Barry Halliwell; Frank Watt
Journal:  Microsc Microanal       Date:  2009-08       Impact factor: 4.127

10.  Spinal Cord Inflammation: Molecular Imaging after Thoracic Aortic Ischemia Reperfusion Injury.

Authors:  Hassan Albadawi; John W Chen; Rahmi Oklu; Yue Wu; Gregory Wojtkiewicz; Benjamin Pulli; John D Milner; Richard P Cambria; Michael T Watkins
Journal:  Radiology       Date:  2016-08-10       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.